"The latest in ASHP's Letters series, Letters from Leaders in Pharmacy encompasses 31 concise, personal stories on pharmacy management and leadership from Pharmacy Leadership Academy (PLA) graduates, faculty, and mentors. Each letter written by pharmacist and technician contributors provides aspiring pharmacy leaders and managers with "2-3" PLA leadership learnings and advice based on the individual's life and work experiences"--
Letters from Leaders in Pharmacy shares the inspiring journeys of 31 pharmacy leaders who have completed or been involved with the Pharmacy Leadership Academy— an online, year-long, rigorous program with a comprehensive curriculum designed to enhance the leadership competence of pharmacists and the pharmacy workforce. These letters will allow you to benefit from others’ leadership journeys and lessons learned including: In the pharmacy content, learning the meaning of leadership and what success looks like. Realizing the value of being nimble and the importance of organizational culture and design. Being in leadership for the right reasons. Learning that empowering your staff entails understanding how the work gets done. Believing in yourself. Appreciating the value of mentors. Observing other leaders and learning from what works and what doesn’t work. And many more
Most of us have received very little, if any, formal training on how to manage our lives and careers. In Letters to a Young Pharmacist: Sage Advice on Life & Career from Extraordinary Pharmacists, find expert advice and guidance for the choices and challenges you will face. Written by 35 leading pharmacists, these very personal letters offer sound advice and insight for seizing or creating opportunities, balancing career and family, avoiding mistakes, and overcoming setbacks. Gain from the wisdom and practical advice offered in these letters on such topics as: Finding the right job or residency Developing productive partnerships The importance of networking Thinking creatively to design new therapies Working well in the culture of your organization Understanding your strengths and weaknesses … and much more. Learn from people who have faced many of the same career and life experiences that lie ahead of you. More than a book, Letters to a Young Pharmacist is a companion guide for your life’s work— and a must-have for every new pharmacist.
Letters from Women in Pharmacy: Stories on Integrating Life and Career focuses on the unique challenges and opportunities faced by women in pharmacy. This collection of 31 personal letters represents experiences of women from a wide array of backgrounds and career paths. Each letter is filled with practical advice, insights, and compelling stories on developing strong support systems and maintaining healthy perspectives on the many roles that women balance to inspire generations of future pharmacy leaders. This Letters publication was stimulated by the ASHP 2016 Women in Pharmacy Leadership Steering Committee recommendation to ASHP: Proactively collect and share stories, case studies and scenarios of how women have addressed gender, workplace, work-life integration, and leadership challenges. The power of this publication comes from each person’s specific journey, all unique but similar in reaching for their potential as both a pharmacist and woman. It emphasizes the multiple successful approaches to blending a career and personal life.
Possibly no one on Earth personally knows as many people at the helms of nations, businesses, religions, charitable organizations, and institutes of learning as Henry O. Dormann—founder, chairman, and editor-in-chief of LEADERS magazine, whose circulation is limited to such leading figures. Here, he brings together the first-ever exclusive collection of wisdom and inspiration addressed to young people from the world’s most influential people—advice on leadership, goal achievement, public service, and life journeys. Letters from Leaders is a beautifully designed book comprising nearly eighty letters from those who have done so much to shape our world today—from Muhammad Ali to four U.S. Presidents, Mikhail Gorbachev, King Bhumibol Adulyadej of Thailand and King Abdullah II of Jordan, and the Dalai Lama; from Cathie Black to T. Boone Pickens, Muriel Siebert, and Donald Trump. The letters, some as facsimile reproductions of handwritten originals, are each introduced with a biographical note by Dormann. As put so aptly by Dormann in his introduction, “All kings and queens, presidents, Nobel Laureates, chairmen and chairwomen, CEOs, and world leaders have one thing in common: They want what they have achieved to be useful and to be handed over to a younger generation. . . . The leaders in these pages have ‘lived’ and now offer their experiences as a treasure to ambitious and open minds—those who want to be something in life.”
Drug-related morbidity and mortality is rampant in contemporary industrial society, despite or perhaps because, government has assumed a critical role in the process by which drugs are developed and approved. Parrish asserts that, as a people, Americans need to understand how it is that government became the arbiter of pharmaceutical fact. The consequences of our failure to understand, he argues, may threaten individual choice and forestall the development of responsible therapeutics. Moreover, if current standards and control continues unabated, the next therapeutic reformation might well make possible the sanctioned commercial exploitation of patients. In Defining Drugs, Parrish argues that the federal government became arbiter of pharmaceutical fact because the professions of pharmacy and medicine, as well as the pharmaceutical industry, could enforce these definitions and standards only through police powers reserved to government. Parrish begins his provocative study by examining the development of the social system for regulating drug therapy in the United States. He reviews the standards that were negotiated, and the tensions of the period between Progressivism and the New Deal that gave cultural context and historical meaning to drug use in American society. Parrish describes issues related to the development of narcotics policy through education and legislation facilitated by James Beal and Edward Kremers, and documents the federal government's evolving role as arbiter of market tensions between pharmaceutical producers, government officials, and private citizens in professional groups, illustrating the influence of government in writing enforceable standards for pharmaceutical therapies. He shows how the expansion of political rights for practitioners and producers has shifted responsibility for therapeutic consequences from individual practitioners and patients to government. This timely and controversial volume is written for the scholar and the compassionate practitioner alike, and a general public concerned with pharmacy regulation in a free society.
